Over half of long COVID patients suffer persistent cognitive slowing, new study reveals

Study finds that 53% of long COVID patients experience significant cognitive slowing, a symptom that does not improve over time and is independent of the severity of the initial SARS-CoV-2 infection.

Gerresheimer AG confirms discussions with private equity investors on potential takeover offer – Biotech Investments

Gerresheimer AG / Key word(s): Tender Offer Gerresheimer AG confirms discussions with private equity investors on potential takeover offer 07-Feb-2025 / 16:26 CET/CEST Disclosure of

February 8, 2025

Eurika Becomes the 5th City In California to Decriminalize Psychedelics | Psychedelic Spotlight

The largest prospective survey of naturalistic psilocybin use to date found that the participants reported persisting reductions in anxiety, depression, and alcohol misuse, increased cognitive

October 21, 2023

Carbios and L’Oréal win Pioneer Award for the world’s first enzymatically recycled cosmetic bottle – Biotech Investments

EQS-News: Carbios SA / Key word(s): Miscellaneous Carbios and L’Oréal win Pioneer Award for the world’s first enzymatically recycled cosmetic bottle 14.11.2023 / 17:30 CET/CEST

November 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.